SCHEMBL1741676

SCHEMBL1741676

CCCCCCCCNC(=N)NC(=N)Nc1ccc(C)cc1

nearest known ligand 0.50

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 1/20 0.50
EPHX1 P07099 5/20 0.46
ALDH1A1 P00352 3/20 0.46
HTT P42858 1/20 0.46
EPHX2 P34913 2/20 0.42
HDAC1 Q13547 1/20 0.41
HDAC2 Q92769 1/20 0.41
NAAA Q02083 2/20 0.40
HPGD P15428 1/20 0.40
LMNA P02545 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
GHSR Q92847 1/20 0.39
CYP1A2 P05177 1/20 0.39
CYP3A4 P08684 1/20 0.39
CYP2C9 P11712 1/20 0.39
CYP2C19 P33261 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26626501 1.00 L3MBTL1 (0.50) L3MBTL1EPHX1ALDH1A1HTTEPHX2
SCHEMBL1741708 0.92 L3MBTL1 (0.54) L3MBTL1EPHX1ALDH1A1HTTEPHX2
SCHEMBL3826641 0.87 LMNA (0.55) EPHX1ALDH1A1HTTEPHX2LMNA
Chlorhexidine SCHEMBL21680261 0.87 LMNA (0.55) EPHX1ALDH1A1HTTEPHX2LMNA
SCHEMBL11814574 0.87 MAPT (0.45) EPHX1ALDH1A1HTTEPHX2HDAC1
SCHEMBL10063826 0.87 SLC6A3 (0.50) ALDH1A1HTTLMNASMN1; SMN2CYP3A4
SCHEMBL12522772 0.87 LMNA (0.55) EPHX1ALDH1A1HTTEPHX2LMNA
SCHEMBL4736495 0.87 EPHX1 (0.61) EPHX1ALDH1A1HTTNAAAGHSR
SCHEMBL1681577 0.87 EPHX1 (0.61) EPHX1ALDH1A1HTTNAAAGHSR
Hydrochloric Acid SCHEMBL4478753 0.85 EPHX1 (0.60) EPHX1ALDH1A1HTTNAAAGHSR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 58 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4180482-B1 MOISTURE-CURABLE COMPOSITION NITTO KASEI CO LTD (JP) 2025-12-03 EP disclosed
US-12479869-B2 Curing catalyst used for curing of polymer, method for producing same, moisture-curable composition, and method for producing cured product NITTO KASEI CO., LTD. (JP) 2025-11-25 US disclosed
EP-4174053-B1 CURING CATALYST USED FOR CURING OF POLYMER, METHOD FOR PRODUCING SAME, MOISTURE-CURABLE COMPOSITION, AND METHOD FOR PRODUCING CURED PRODUCT NITTO KASEI CO LTD (JP) 2025-11-19 EP disclosed
EP-4569023-A1 COMBINATION OF CATALYTIC COMPONENTS PolyU GmbH (DE) 2025-06-18 EP disclosed
US-12264275-B2 Treatment liquid FUJIFILM CORPORATION (JP) 2025-04-01 US disclosed
CN-115516041-B Curing catalyst for curing polymer, method for producing same, moisture-curable composition, and method for producing cured product 日东化成株式会社 2024-06-28 CN disclosed
WO-2024033348-A1 COMBINATION OF CATALYTIC COMPONENTS POLYU GMBH (DE) 2024-02-15 WO disclosed
EP-4321573-A1 COMBINATION OF CATALYTIC COMPONENTS PolyU GmbH (DE) 2024-02-14 EP disclosed
US-20240002725-A1 COMPOSITION AND METHOD FOR TREATING SUBSTRATE FUJIFILM CORPORATION (JP) 2024-01-04 US disclosed
CN-117062940-A Composition and method for treating substrate 富士胶片株式会社 2023-11-14 CN disclosed
US-20150159124-A1 CLEANING FORMULATION FOR REMOVING RESIDUES ON SURFACES FUJIFILM ELECTRONIC MATERIALS U.S.A., INC. 2015-06-11 US disclosed
WO-2015084921-A1 CLEANING FORMULATION FOR REMOVING RESIDUES ON SURFACES FUJIFILM ELECTRONIC MATERIALS U.S.A., INC. (US) 2015-06-11 WO disclosed
US-20150099849-A1 CURABLE COMPOSITION, AND CURED SYNTHETIC RESIN USING SAME MIE UNIVERSITY (JP) 2015-04-09 US disclosed
EP-2837660-A1 CURABLE COMPOSITION, AND CURED SYNTHETIC RESIN USING SAME Mie University (JP) 2015-02-18 EP disclosed
US-8853309-B2 Curable composition and cured product thereof KANEKA CORPORATION (JP) 2014-10-07 US disclosed
EP-2338938-B1 CURABLE COMPOSITION AND CURED PRODUCT THEREOF KANEKA CORP (JP) 2013-07-31 EP disclosed
EP-2388297-A1 CURABLE COMPOSITION AND CURED OBJECT FORMED THEREFROM Kaneka Corporation (JP) 2011-11-23 EP disclosed
US-20110237723-A1 CURABLE COMPOSITION AND CURED PRODUCT THEREOF KANEKA CORPORATION (JP) 2011-09-29 US disclosed
EP-2338938-A1 CURABLE COMPOSITION AND CURED PRODUCT THEREOF Kaneka Corporation (JP) 2011-06-29 EP disclosed
EP-2267083-A1 CURABLE COMPOSITION AND CURED MATERIAL Kaneka Corporation (JP) 2010-12-29 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12479869-B2 Curing catalyst used for curing of polymer, method for producing same, moisture-curable composition, and method for producing cured product KDM2B, SETDB1, ASH2L L3MBTL1 3304/4885EPHX1 984/4885ALDH1A1 615/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.